Luippold G - Search Results

1

Characterization of Micro-RNA Changes during the Progression of Type 2 Diabetes in Zucker Diabetic Fatty Rats.

Delic D, Eisele C, Schmid R, Luippold G, Mayoux E, Grempler R. Delic D, et al. Among authors: luippold g. Int J Mol Sci. 2016 May 3;17(5):665. doi: 10.3390/ijms17050665. Int J Mol Sci. 2016. PMID: 27153060 Free PMC article.

2

Short- and Longterm Glycemic Control of Streptozotocin-Induced Diabetic Rats Using Different Insulin Preparations.

Luippold G, Bedenik J, Voigt A, Grempler R. Luippold G, et al. PLoS One. 2016 Jun 2;11(6):e0156346. doi: 10.1371/journal.pone.0156346. eCollection 2016. PLoS One. 2016. PMID: 27253523 Free PMC article.

3

Discovery and translation of a target engagement marker for AMP-activated protein kinase (AMPK).

Grempler R, Wolff M, Simon E, Schmid R, Eisele C, Rieber K, Fischer E, Mettel S, Gabrielyan O, Delic D, Luippold G, Redeman N. Grempler R, et al. Among authors: luippold g. PLoS One. 2018 May 25;13(5):e0197849. doi: 10.1371/journal.pone.0197849. eCollection 2018. PLoS One. 2018. PMID: 29799853 Free PMC article.

4

Empagliflozin, a novel potent and selective SGLT-2 inhibitor, improves glycaemic control alone and in combination with insulin in streptozotocin-induced diabetic rats, a model of type 1 diabetes mellitus.

Luippold G, Klein T, Mark M, Grempler R. Luippold G, et al. Diabetes Obes Metab. 2012 Jul;14(7):601-7. doi: 10.1111/j.1463-1326.2012.01569.x. Epub 2012 Feb 23. Diabetes Obes Metab. 2012. PMID: 22268612

5

Blood glucose profiles in diabetic rodents using different insulin preparations.

Schneider S, Weber R, Luippold G. Schneider S, et al. Among authors: luippold g. Arzneimittelforschung. 2004;54(12):842-6. doi: 10.1055/s-0031-1297039. Arzneimittelforschung. 2004. PMID: 15646368

6

Chronic renal denervation prevents glomerular hyperfiltration in diabetic rats.

Luippold G, Beilharz M, Mühlbauer B. Luippold G, et al. Nephrol Dial Transplant. 2004 Feb;19(2):342-7. doi: 10.1093/ndt/gfg584. Nephrol Dial Transplant. 2004. PMID: 14736957

7

Effect of dopamine D3 receptor blockade on renal function and glomerular size in diabetic rats.

Luippold G, Beilharz M, Wehrmann M, Unger L, Gross G, Mühlbauer B. Luippold G, et al. Naunyn Schmiedebergs Arch Pharmacol. 2005 May;371(5):420-7. doi: 10.1007/s00210-005-1030-1. Epub 2005 May 11. Naunyn Schmiedebergs Arch Pharmacol. 2005. PMID: 15887004

8

Effect of L-dopa decarboxylase inhibitor benserazide on renal function in streptozotocin-diabetic rats.

Pfeil K, Staudacher T, Luippold G. Pfeil K, et al. Among authors: luippold g. Kidney Blood Press Res. 2006;29(1):43-7. doi: 10.1159/000092849. Epub 2006 Apr 20. Kidney Blood Press Res. 2006. PMID: 16636577

9

An antibody against the C-terminal domain of PCSK9 lowers LDL cholesterol levels in vivo.

Schiele F, Park J, Redemann N, Luippold G, Nar H. Schiele F, et al. Among authors: luippold g. J Mol Biol. 2014 Feb 20;426(4):843-52. doi: 10.1016/j.jmb.2013.11.011. Epub 2013 Nov 16. J Mol Biol. 2014. PMID: 24252255

10

Reduction of glomerular hyperfiltration by dopamine D(2)-like receptor blockade in experimental diabetes mellitus.

Luippold G, Beilharz M, Mühlbauer B. Luippold G, et al. Nephrol Dial Transplant. 2001 Jul;16(7):1350-6. doi: 10.1093/ndt/16.7.1350. Nephrol Dial Transplant. 2001. PMID: 11427624

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

56 results

Search Page

Filters